{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-001406","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2026-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.683385+00:00","generated_at":"2026-05-15T17:52:17.903342+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Profound Medical to present first CAPTAIN trial outcomes at EAU 2026, host investor call March 13","bullets":["First CAPTAIN trial outcomes (TULSA vs radical prostatectomy) presented at EAU 2026 on March 13 at 9:40 a.m. EDT.","Investor webinar at 11:30 a.m. EDT on March 13 with Dr. Laurence Klotz reviewing data and commercial implications.","Management to participate in Roth Conference March 22-24 in Dana Point, CA; one-on-one meetings."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-001406","json":"https://secwatch.observer/filing/0001171843-26-001406.json","markdown":"https://secwatch.observer/filing/0001171843-26-001406.md","text":"https://secwatch.observer/filing/0001171843-26-001406.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326001406/0001171843-26-001406-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326001406/f8k_030926.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T17:52:17.903342+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}